Anxiety symptoms not worsened by COVID-19 pandemic (n = 16)

Anxiety symptoms worsened by COVID-19 pandemic (n = 86)

P value

Male

4 (25.0%)

19 (21.1%)

0.754

Female

12 (75.0%)

67 (77.9%)

Compared with

Pre-COVID-19

GAD-7 same or decrease

11 (68.8%)

49 (57%)

0.547

GAD-7 increase

5 (31.3%)

37 (43%)

PHQ-9 same or decrease

12 (75.0%)

49 (57%)

0.283

PHQ-9 increase

4 (25.0%)

37 (43%)

Medications

0.757

Same dosage

13 (81.3%)

65 (75.6%)

Step up or add new medications

3 (18.8%)

21 (24.4%)

Social distancing

0.006

Absent

3 (18.8%)

5 (5.8%)

Mild

7 (43.8%)

16 (18.6%)

Moderate

4 (25.0%)

38 (44.2%)

Severe

2 (12.5%)

27 (31.4%)

Financial impact

Decreased income/unemployed

2 (12.5%)

16 (18.6%)

0.731

Not affected

14 (87.5%)

70 (81.4%)

Family relationship

0.913

Worsen

4 (25.0%)

27 (31.4%)

Not affected

11 (68.8%)

51 (59.3%)

Improved

1 (3.0%)

8 (9.3%)

Mean (SD)

Mean (SD)

GAD-7 (Pre-COVID-19)

4.5 (3.97)

4.92 (2.92)

0.692

PHQ-9 (Pre-COVID-19)

4 (3.54)

3.45 (2.42)

0.560

GAD-7 (Peri-COVID-19)

3.13 (2.71)

4.85 (3.04)

0.037

PHQ-9 (Peri-COVID-19)

2.81 (2.79)

3.52 (2.35)

0.283

Anxiety worsen by COVID-19

Mean GAD-7 (Pre-COVID-19) 4.92

Mean GAD-7 (Pre-COVID-19) 4.85

0.801

Mean PHQ-9 (Pre-COVID-19) 3.45

Mean PHQ-9 (Pre-COVID-19) 3.52

0.796